CORE ADANIPORTS+0.24% BIRET-0.24% BRIGADE-0.85% DLF-1.17% EMBASSY+1.10% GMRAIRPORT+0.00% GODREJPROP+0.19% IRB+3.46% LODHA-0.98% LT-1.76% MAHLIFE-1.64% MINDSPACE-1.39% NCC-0.64% OBEROIRLTY-0.14% PHOENIXLTD+0.11% PRESTIGE-0.22% SOBHA+0.95% as of 2026-08-26 14:06 UTC

The Annexure

Desk› Healthcare› Orchid Pharma Ltd

Orchid Pharma Ltd

BSE 524372 ORCHPHARMA INE191A01027
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Filing rhythm · 30 trading days

11 filings · 4 material · busiest 2026-08-14

What it files

Analyst / Investor Meet2 Board Meeting2 Concall Transcript1 Investor Presentation1 Board Outcome1 Results1 General1 Monitoring Agency1

Filings

11 in the window

  1. 24 August 2026

    Concall Transcript

    Earnings Call Transcript

    Transcript of Analysts/Investors earning call held with public at large on August 21, 2026.

    Company Update / Earnings Call Transcript View filing →

  2. 21 August 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Outcome

    Audio Recording of the Analyst/Investor Earning Call for Q-1 ended on June 30, 2026

    Company Update / Analyst / Investor Meet View filing →

  3. 20 August 2026

    Investor Presentation

    Investor Presentation

    Investors Presentation-Quarter 1 of F.Y.2026-27, ended on June 30, 2026.

    Company Update / Investor Presentation View filing →

  4. 17 August 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Intimation of schedule of Analysts/Investors Earning call for the Quarter-1 ended on June 30, 2026.

    Company Update / Analyst / Investor Meet View filing →

  5. 14 August 2026

    Board Outcome

    Board Meeting Outcome for Outcome Of Board Meeting

    Outcome of Board meeting inter alia for considering and approving Unaudited Financial Results for Quarter-1 of F.Y. 2026-27, ended on June 30, 2026.

    Board Meeting / Outcome of Board Meeting View filing →

  6. 14 August 2026

    Results

    Financial Results For Quarter-1 Of F.Y. 2026-27 Ended June 30, 2026.

    Financial Results for Quarter-1 of F.Y. 2026-27 ended on June 30, 2026.

    Result / Financial Results View filing →

  7. 14 August 2026

    General

    Outcome Of Board Meeting Held For Considering And Approving Revised Audited Financial Results For The Year Ended March 31, 2026 Pursuant To Scheme Of Merger.

    Revised Audited financial results for the Financial year ended March 31, 2026 pursuant to Scheme of Merger

    Company Update / General View filing →

  8. 14 August 2026

    Monitoring Agency

    Monitoring Agency Report

    Monitoring Agency Report for Quarter-1 of F.Y. 2026-27 ended June 30, 2026.

    Company Update / Monitoring Agency Report View filing →

  9. 14 August 2026

    Other Update

    Statement Of Deviation Or Variation For The Quarter Ended June 30, 2026 On The Use Of Proceeds Of Funds Raised Through Qualified Institutional Placement

    Statement of Deviation or variation for the quarter ended June 30, 2026 on the use of proceeds of Funds raised through Qualified Institutional Placement.

    Company Update / Reg. 32 (1), (3) - Statement of Deviation & Variation View filing →

  10. 11 August 2026

    Board Meeting

    Board Meeting Intimation for Prior Intimation Of Board Meeting Scheduled To Be Held On August 14, 2026.

    Orchid Pharma Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve Unaudited Limited reviewed financial ....

    Board Meeting / Board Meeting View filing →

  11. 28 July 2026

    Board Meeting

    Board Meeting Intimation for Prior Intimation Of Board Meeting Scheduled To Be Held On August 01, 2026

    Orchid Pharma Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2026 ,inter alia, to consider and approve Prior intimation of Board Meeting ....

    Board Meeting / Board Meeting View filing →